Rockwell Medical Q2 2024 Adj. EPS $0.05 Beats $(0.04) Estimate, Sales $25.800M Beat $22.921M Estimate
Portfolio Pulse from Benzinga Newsdesk
Rockwell Medical reported Q2 2024 adjusted EPS of $0.05, beating the estimate of $(0.04). Sales were $25.8 million, surpassing the $22.921 million estimate.
August 08, 2024 | 10:01 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rockwell Medical reported Q2 2024 adjusted EPS of $0.05, significantly beating the estimate of $(0.04). Sales were $25.8 million, also surpassing the $22.921 million estimate.
The significant beat on both EPS and sales estimates is likely to positively impact Rockwell Medical's stock price in the short term. Investors typically react favorably to such earnings surprises.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100